Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $883.80 | 16 | 96.5% |
| Education | $32.27 | 1 | 3.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $804.75 | 14 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $100.20 | 2 | $0 (2020) |
| ASSERTIO THERAPEUTICS, Inc. | $11.12 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $121.74 | 4 | Novo Nordisk Inc ($121.74) |
| 2020 | $18.82 | 1 | AstraZeneca Pharmaceuticals LP ($18.82) |
| 2019 | $203.80 | 4 | Novo Nordisk Inc ($192.68) |
| 2018 | $106.05 | 2 | Novo Nordisk Inc ($106.05) |
| 2017 | $465.66 | 6 | Novo Nordisk Inc ($384.28) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: Diabetes | ||||||
| 06/10/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $98.72 | General |
| Category: Diabetes | ||||||
| 04/30/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.28 | General |
| Category: Diabetes | ||||||
| 03/09/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: Diabetes | ||||||
| 04/21/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Respiratory | ||||||
| 08/07/2019 | ASSERTIO THERAPEUTICS, Inc. | Gralise (Drug), Zipsor, Cambia | Food and Beverage | In-kind items and services | $11.12 | General |
| Category: Neurology | ||||||
| 07/12/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $8.52 | General |
| Category: Diabetes | ||||||
| 04/17/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $113.90 | General |
| Category: Diabetes | ||||||
| 04/10/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $70.26 | General |
| Category: Obesity | ||||||
| 11/14/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes | ||||||
| 03/22/2018 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $96.64 | General |
| Category: Diabetes | ||||||
| 10/19/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $105.45 | General |
| Category: Diabetes | ||||||
| 09/12/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $81.38 | General |
| Category: Respiratory | ||||||
| 07/11/2017 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $65.11 | General |
| Category: Obesity | ||||||
| 05/31/2017 | Novo Nordisk Inc | Saxenda (Drug) | Education | In-kind items and services | $32.27 | General |
| Category: Obesity | ||||||
| 04/20/2017 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $92.58 | General |
| Category: Diabetes | ||||||
| 03/07/2017 | Novo Nordisk Inc | Victoza (Drug) | Food and Beverage | In-kind items and services | $88.87 | General |
| Category: Diabetes | ||||||
About Dr. Peter Ault, MD
Dr. Peter Ault, MD is a Internal Medicine healthcare provider based in Hopewell, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134192602.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Ault, MD has received a total of $916.07 in payments from pharmaceutical and medical device companies, with $121.74 received in 2021. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($883.80).
Practice Information
- Specialty Internal Medicine
- Location Hopewell, VA
- Active Since 02/07/2006
- Last Updated 09/07/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1134192602
Products in Payments
- Tresiba (Drug) $311.64
- Victoza (Drug) $203.73
- Saxenda (Drug) $167.64
- RYBELSUS (Drug) $106.49
- BEVESPI AEROSPHERE (Drug) $81.38
- SYMBICORT (Drug) $18.82
- Ozempic (Drug) $15.25
- Gralise (Drug) $11.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hopewell
Albert Magnin, Md, MD
Internal Medicine — Payments: $50,871
Mohammad Mujeebuddin, Md, MD
Internal Medicine — Payments: $6,047
Manu Gadani, Md, MD
Internal Medicine — Payments: $2,570
James Bush, Md, MD
Internal Medicine — Payments: $745.29
Brent Armstrong, Md, MD
Internal Medicine — Payments: $233.37